EU Parliament Trilogue Negotiations on AI Act Compliance Deadline Extensions

Applies To

Overview

Media reports from early 2026 indicate the European Parliament intends to initiate formal trilogue negotiations in April or early May 2026 on a set of amendments that would defer compliance deadlines embedded in the EU AI Act. The reported proposed changes would extend the deadline for high-risk AI systems, currently governed by Title III of the AI Act, from its existing date to December 2027, and would shift the deadline for AI systems integrated into regulated products to August 2028. These extensions are understood to address industry-reported difficulties in meeting conformity assessment, technical documentation, and registration requirements that became operative under the Act's earlier implementation phases. Trilogue negotiations involve iterative negotiation between the three principal EU institutions and have no fixed duration, meaning the timeline for any amending instrument to reach final adoption remains uncertain. Until a formal amending regulation or decision is adopted and published in the Official Journal of the European Union, existing statutory deadlines under the AI Act remain legally binding. Compliance officers should treat this development as unconfirmed and monitor official EU legislative tracker publications for authoritative status updates.

Key Requirements

• •No binding obligations arise from this pending process; existing EU AI Act deadlines remain in force until formally amended
• •If adopted, high-risk AI system compliance deadline would shift to approximately December 2027, extending the current statutory date
• •If adopted, compliance deadline for AI systems embedded in regulated products subject to existing EU product safety directives would shift to approximately August 2028
• •Trilogue negotiations are expected to commence April or May 2026; final adoption timeline is not established
• •Any adopted amendments must be published in the Official Journal of the EU before they carry legal effect
• •Enterprises should not defer conformity assessment or documentation activities based solely on media reporting of proposed extensions

What Your Organization Must Do

• →Monitor the EU legislative tracker (EUR-Lex and the European Parliament's Legislative Observatory) at least bi-weekly starting April 2026 to capture any official trilogue launch notice or adopted amending instrument, assigning this task to your regulatory affairs lead.
• →Continue all ongoing conformity assessment, technical documentation, and registration activities under existing EU AI Act deadlines as if no extension will be granted, since current statutory dates remain legally binding until an amendment is published in the Official Journal of the EU.
• →Brief your board or risk committee now on the distinction between reported proposed extensions and binding law, ensuring internal project plans and budget approvals for high-risk AI compliance are not deferred based on unconfirmed media reporting.
• →Prepare a contingency compliance roadmap with two tracks: one targeting the current statutory deadlines and one incorporating the proposed extensions to December 2027 for high-risk AI systems under Title III and August 2028 for product-embedded AI, so your team can pivot quickly once final adoption status is confirmed.
• →Engage your external EU regulatory counsel to review any amending regulation promptly upon publication in the Official Journal, verifying scope, transition provisions, and whether your specific AI system classifications are covered before adjusting internal timelines.
• →Document all monitoring steps, internal decisions, and rationale in your compliance log to demonstrate good-faith adherence to current obligations, which will be critical if regulators scrutinize activity during the negotiation period.

Playbook Guidance

Step-by-step implementation guidance for compliance teams.

Frequently Asked Questions

Are the reported EU AI Act deadline extensions legally binding now?

No. The proposed extensions are not legally binding until a formal amending regulation is adopted and published in the Official Journal of the EU. Trilogue negotiations have not concluded, and existing statutory deadlines under the AI Act remain fully in force. Companies must continue complying with current deadlines.

What specific deadlines would the trilogue amendments extend if adopted?

Reported proposals would shift the compliance deadline for high-risk AI systems under Title III from its current date to December 2027, and move the deadline for AI systems embedded in regulated products to August 2028. Neither extension is confirmed or legally effective at this time.

When are EU trilogue negotiations on the AI Act deadline extensions expected to begin?

Media reports indicate the European Parliament intends to launch formal trilogue negotiations in April or early May 2026. Trilogue processes have no fixed duration, so a final adoption date cannot be estimated with confidence.

Can we pause conformity assessment work for high-risk AI systems while trilogue negotiations are ongoing?

No. Suspending conformity assessment, technical documentation, or registration activities based on unconfirmed media reporting of proposed extensions creates direct legal exposure. Current statutory deadlines remain binding until an amendment is formally published in the Official Journal of the EU.

Where can compliance teams track the official status of these AI Act amendment negotiations?

Monitor EUR-Lex and the European Parliament's Legislative Observatory for official trilogue launch notices and adopted amending instruments. These are the authoritative sources; media reporting should not substitute for direct legislative tracker review.

How do these proposed extensions compare to the original EU AI Act phased compliance schedule?

The EU AI Act's initial phased obligations became operative in February and August 2025. The proposed amendments would add roughly one to two additional years for high-risk and product-embedded AI systems, responding to industry-reported difficulties with conformity assessment and registration requirements under those earlier phases.